----
Current ValuationThe current P/E ratio is 43.45, above the reasonable range, cheaper than 0.26% of the time in the past 3 years, and the industry ranks 22/84, the industry Median 20.41.
43.45xP/E
¥9.71Stock price
¥0.22Earnings per share
43.45xP/E
Stock price¥9.71Earnings per share¥0.22
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 24.84x
- Typical range
- 21.72x–33.34x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 20.41x
022446688
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 20.41x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
002675SZDongcheng Biochem | 50.59x | 51.77% | ¥10.63B |
000403SZPLBIO | 43.45x | 94.32% | ¥9.23B |
000534SZWEDGE CORPORATION | 48.12x | 44.07% | ¥8.23B |
300639SZHybribio Biotech | 54.21x | -- | ¥3.61B |
688136SHSDKX | 43.40x | 21.52% | ¥3.05B |
603739SHVland Biotech | 41.16x | 25.00% | ¥2.92B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
